As Delhi’s AQI hits a new high, it is essential to know the effect it can have on our skin. Know the preventive measures from ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...

Enhances Aclaris’ pipeline with complementary biologics portfolio -- Expands leadership team with addition of seasoned biotech executives -- ...

Biosion, Inc., a R&D stage biotechnology company, announced Monday that it has entered into an exclusive license agreement with ...

Biosion, Inc. (Biosion), a global R&D stage biotechnology company, today announced that it has entered into an exclusive license agreement with Aclaris Therapeutics (NASDAQ: ACRS) for worldwide rights ...

When Incyte inked the takeover, the X2 candidate had shown proof-of-mechanism in chronic inducible urticaria (CIndU ...

Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the Investigator's Global ...

NKTR-422 demonstrated inflammation resolution and tissue repair in multiple preclinical models of chronic inflammatory conditions - SAN FRANCISCO, Nov. 18, 2024 ...

An Auckland-based artist living with debilitating symptoms of topical steroid withdrawal (TSW) believes his dermatologists ...

Allergies to inhaled environmental allergens, also known as atopic dermatitis, are estimated to affect 10-15 ... Apoquel may be more effective at managing severe and chronic allergies in dogs. Atopica ...